Novo Nordisk (NVO) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
This move lagged the S&P 500's daily gain of 2.51%. Meanwhile, the Dow gained 2.85%, and the Nasdaq, a tech-heavy index, added 2.8%. Prior to today's trading, shares of the drugmaker had lost 4.67% was narrower than the Medical sector's loss of 5.12% and lagged the S&P 500's loss of 1.66%. Market participants will be closely following the financial results of Novo Nordisk in its upcoming release. The company's upcoming EPS is projected at $0.87, signifying a 5.43% drop compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $11.13 billion, indicating a 1.08% growth compared to the corresponding quarter of the prior year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $3.37 per share and a revenue of $45.22 billion, signifying shifts of -14.9% and -3.32%, respectively, from the last year. Investors should also take note of any recent adjustments to analyst estimates for Novo Nord
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk A/S (NVO) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c-)".MarketBeat
- Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker? [Yahoo! Finance]Yahoo! Finance
- CNBC's UK Exchange newsletter: Brace yourself for rising bills as new tax year kicks off Share [CNBC]CNBC
- Vltava Fund Q1 2026 Letter To Shareholders [Seeking Alpha]Seeking Alpha
- Assessing Novo Nordisk (CPSE:NOVO B) Valuation After Recent Share Price Volatility [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/7/26 - Form 6-K
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website